Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin

Clinical trial NCT02019212 · COMPLETED

Trial details

NCT number: NCT02019212
Sponsor: Ottawa Heart Institute Research Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

Cardiovascular Disease

Start date: 2013-06-01
Primary completion: 2016-10-27
Enrollment: 4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.